Preclinical and clinical evidence has highlighted the role of the activation of TRP channels (mainly TRPA1) in the pathophysiology of various chronic pain (such as migraine) by promoting CGRP release [93, 94]. The gene discussed is TRPA1; the disease is migraine disorder.